Yale researchers design better way discover drug candidates

Yale researchers design a better way to discover drug candidates

3:09 PM, 6th July 2011
Yale researchers design a better way to discover drug candidates

NEW HAVEN, US: Yale researchers have devised a novel way to trick cells into getting rid of problematic proteins, a method that could help pharmaceutical companies quickly identify promising targets for new drugs.

“Our new approach offers great potential in overcoming a key stumbling block in drug development today: the validation of drug target proteins in living organisms,” said Craig Crews, the Lewis B Cullman Professor of Molecular, Cellular and Developmental Biology, Professor of Chemistry and Pharmacology, Member of the Yale Cancer Centre and Senior Author of the study.

The work is reported online July 3 in the journal Nature Chemical Biology.

Drug companies spend hundreds of millions of dollars to design small molecules that fit into folds of proteins and inhibit their function. The new technique developed by Crews and his team will help determine which of these proteins are good targets for drug development.

The research team decided to mimic the cell’s natural quality control mechanisms that mark defective proteins for destruction. They created a chemical compound that resembles a partially denatured protein, a state that triggers cellular mechanisms to slice up a protein.  The team then attached the compound, which Crews says resembles a “greasy knob,” to proteins of interest. Using green fluorescent markers, the team found that the technique destroyed a variety of protein types in both cell culture and in live animals.

Crews said the technique has many advantages over existing target validation strategies. “This strategy also has general utility in controlling protein function and we believe it will undoubtedly have many new unforeseen applications,” said Crews.

© Yale University News




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Plastic cell membranes for faster and cheaper drug development

Synthetic cell membranes invented at the Institute of Materials Research and Engineering (IMRE), a research institute of Singapore’s Agency for ...

Read more
Elevance and Hutchinson collaborate for rubber processing

BOLINGBROOK,US: Elevance Renewable Sciences Inc and Paris-based Hutchinson Worldwide announce a collaboration to validate the use of Elevance’s ...

Read more
Foster Wheeler awarded contract by Saudi Aramco in Saudi Arabia

  ZUG, SWITZERLAND: Foster Wheeler AG announced that Foster Wheeler SOFCON, an unincorporated consortium between a subsidiary of Foster Wheeler& ...

Read more
Dow Chemicals in talks to acquire Yule Catto - market rumours

  LONDON, UNITED KINGDOM: Industry rumours sepculate, Dow Chemical is said to be in talks with Yule Catto, a specialty chemical maker. According ...

Read more
Foster Wheeler gets design contract for a new refinery in Venezuela

  ZUG, SWITZERLAND: Foster Wheeler AG’s subsidiary of its Global Engineering and Construction Group has been awarded a process design and ...

Read more
Ube licenses lithium-ion rechargeable battery technology to ATL

TOKYO, JAPAN: Ube Industries Ltd will license several Ube-owned patents on lithium-ion rechargeable batteries and electrolytes to Amperex Technology L ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X